Guidelines

An International MDS/MPN Working Group’s perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms

Tufts University Medical Center, Boston, MA, USA
Wessex Regional Genetics Laboratory, Salisbury, UK
H. Lee Moffitt Cancer Center, Tampa, FL, USA
Cleveland Clinic Taussig Cancer Institute, OH, USA
Vanderbilt University Medical Center, Nashville, TN, USA
University of Pavia Medical School, S. Matteo University Hospital, Pavia, Italy
Mayo Clinic Cancer Center, Scottsdale, AZ, USA
H. Lee Moffitt Cancer Center, Tampa, FL, USA
Hôpital Saint-Louis, Paris 7, France
MD Anderson Cancer Center, Houston, TX, USA
Weill Cornell Medical College, New York, NY, USA
Mayo Clinic Cancer Center, Scottsdale, AZ, USA
Cleveland Clinic Taussig Cancer Institute, OH, USA
Hôpital Saint-Louis, Paris 7, France
Hôpital Saint-Louis, Paris 7, France
King’s College Hospital, GKT School of Medicine, London, UK
Institut Gustave Roussy, Villejuif, France
H. Lee Moffitt Cancer Center, Tampa, FL, USA
Vol. 100 No. 9 (2015): September, 2015 https://doi.org/10.3324/haematol.2014.114660